H 1222
An Act relative to prescription medication re-authorization
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to prevent health insurers in Massachusetts from requiring annual re-authorizations for certain prescription medications. Currently, insurers often require patients to get new approvals each year for continued access to their medications, which can disrupt treatment and create barriers to care. The bill seeks to ensure patients can continue receiving necessary medications without repeated authorization processes. It focuses on streamlining the process for ongoing prescriptions.
Key provisions
- Prohibits annual re-authorizations for certain prescription drugs.
- Applies to health insurers operating in Massachusetts.
- Allows for re-authorization based on medical necessity.
- Preserves the ability of healthcare providers to determine appropriate treatment plans.
- Addresses the potential for unnecessary administrative burdens for patients and providers.
- Focuses on medications that are essential for ongoing treatment.
Who is affected
- Patients receiving long-term prescription medications
- Health insurers in Massachusetts
- Prescription drug providers
- Healthcare providers
Notable changes
- Eliminates the requirement for annual re-authorization for specific medications.
- Simplifies the prescription medication process for patients.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Sally P. Kerans
Cosponsor
Sally P. Kerans
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.1222 194th (Current)
An Act relative to prescription medication re-authorization
By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 1222) of Sally P. Kerans relative to prohibiting insurers from requiring annual re-authorizations for certain prescription drugs. Financial Services.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Sally P. Kerans Status: Referred to Joint Committee on Health Care Financing
Tabs
Bill History Petitioners Committee Vote Committee Summary Hearing Attendance
Bill History
Displaying 6 actions for Bill H.1222
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Financial Services |
| 2/27/2025 | Senate | Senate concurred |
| 6/3/2025 | Joint | Hearing scheduled for 06/10/2025 from 10:30 AM-01:00 PM in A-2 |
| 9/18/2025 | House | Reported favorably by committee and referred to the committee on Health Care Financing |
| 12/8/2025 | House | Reporting date extended to Wednesday, March 18, 2026 |
| 3/19/2026 | House | Reporting date extended to Monday, June 15, 2026 |
Similar Bills
H.3757 193rd (2023 - 2024)
An Act relative to prescription medication re-authorization
H.1606 194th (Current)
An Act relative to law enforcement access to prescription monitoring data
H.2414 194th (Current)
An Act relative to patient assessment and notification prior to prescribing certain medications
H.1324 194th (Current)
An Act relative to prescription drug pricing
H.1133 194th (Current)
An Act relative to patient financial protection
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.